Glutamate-gated chloride channels and the mode of action of the avermectin/milbemycin anthelmintics.

Department of Biology and Biochemistry, University of Bath, Claverton Down, Bath BA2 7AY, UK.
Parasitology (Impact Factor: 2.35). 02/2005; 131 Suppl:S85-95. DOI: 10.1017/S0031182005008218
Source: PubMed

ABSTRACT The macrocyclic lactones are the biggest selling and arguably most effective anthelmintics currently available. They are good substrates for the P-glycoproteins, which might explain their selective toxicity for parasites over their vertebrate hosts. Changes in the expression of these pumps have been implicated in resistance to the macrocyclic lactones, but it is clear that they exert their anthelmintic effects by binding to glutamate-gated chloride channels expressed on nematode neurones and pharyngeal muscle cells. This effect is quite distinct from the channel opening induced by glutamate, the endogenous transmitter acting at these receptors, which produces rapidly opening and desensitising channels. Ivermectin-activated channels open very slowly but essentially irreversibly, leading to a very long-lasting hyperpolarisation or depolarisation of the neurone or muscle cell and therefore blocking further function. Molecular and genetic studies have shown that there are multiple GluCl isoforms in both free-living and parasitic nematodes: the exact genetic make-up and functions of the GluCl may vary between species. The known expression patterns of the GluCl explain most of the observed biological effects of treatment with the macrocyclic lactones, though the reason for the long-lasting inhibition of larval production in filarial species is still poorly understood.

1 Bookmark
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Neglected tropical diseases (NTDs), malaria, and tuberculosis have a devastating effect on an estimated 1.6 billion people worldwide. The World Intellectual Property Organization (WIPO) Re:Search consortium accelerates the development of new drugs, vaccines, and diagnostics for these diseases by connecting the assets and resources of pharmaceutical companies, such as compound libraries and expertise, to academic or nonprofit researchers with novel product discovery or development ideas. As the WIPO Re:Search Partnership Hub Administrator, BIO Ventures for Global Health (BVGH) fields requests from researchers, identifies Member organizations able to fulfill these requests, and helps forge mutually beneficial collaborations. Since its inception in October 2011, WIPO Re:Search membership has expanded to more than 90 institutions, including leading pharmaceutical companies, universities, nonprofit research institutions, and product development partnerships from around the world. To date, WIPO Re:Search has facilitated over 70 research agreements between Consortium Members, including 11 collaborations focused on anthelmintic drug discovery.
    International Journal for Parasitology: Drugs and Drug Resistance. 12/2014;
  • [Show abstract] [Hide abstract]
    ABSTRACT: Evaluate use of spherical nanocarbon (Grafex) injected into known Human Prostatic carcinoma to increase absorption of microwave energy, specifically into tumor cells. This study was selected to evaluate if nanocarbon and microwave can be used as primary treatment and selected to study heat sink associated with microwave treatment. This specific nanocarbon has demonstrated a range of energy absorption capabilities superior to other non-metallic materials.Materials and Methods10 Nude nu/nu mice were injected with DU145 (ATC#HTB-81) 1x 10^7 Human Prostate carcinoma cells introducted into the dermis and allowed to grow to >1cm. One control mouse received no treatment. One control mouse received only an injection of nanocarbon. Remaining 8 mice received treatment with the microwave and the nanocarbon. Medwave and BSD magnetron generators with temperature probes were used. Nanocarbon and a viscous carrier were injected into the tumors. Short cycle power using 10 watts at 15 seconds used as baseline settings. Target temperature within the tumor was 60 degrees C.ResultsThe control non treated mouse was euthanized due to metastatic prostate cancer 3 weeks after initial injection. Seven of the original treated mice have resolved their prostate tumors with no apparent ill effects from the nanocarbon. One mouse had a non treated skin ulcer from the non cooled microwave probe during the treatment process and was also euthanized ,however, was responding to treatment. The one mouse that received just the nanocarbon treatment, is alive, however the tumor growth has not receded or advanced. All mice were kept in isolation and were observed to have no side effects from the nanocarbon.Conclusion Nanocarbon assisted microwave therapy maximizes energy transfer. Conversion of microwave energy causes thermal ablation to the cancer cells. This reduces heat sink effect and surrounding tissue damage by using much shorter treatment times and lower power output wattage. This suggests Grafex nanocarbon causes enhancement of the dielectric properties of the tumor causing cytotoxic heating. To date, there is no observed toxic side effects in mice from this small study.
    Journal of Vascular and Interventional Radiology 04/2013; 24(4):S116-S117. · 2.15 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: The cattle tick Rhipicephalus (Boophilus) microplus is the most economically important ectoparasite affecting the cattle industry in tropical and subtropical areas around the world. The principal method of tick control has relied mainly on the use of chemical acaricides, including ivermectin; however, cattle tick populations resistant to ivermectin have recently been reported in Brazil, Mexico, and Uruguay. Currently, the molecular basis for ivermectin susceptibility and resistance are not well understood in R. microplus. This prompted us to search for potential molecular targets for ivermectin. Here, we report the cloning and molecular characterization of a R. microplus glycine-like receptor (RmGlyR) gene. The characterized mRNA encodes for a 464-amino acid polypeptide, which contains features common to ligand-gated ion channels, such as a large N-terminal extracellular domain, four transmembrane domains, a large intracellular loop and a short C-terminal extracellular domain. The deduced amino acid sequence showed around 30% identity to GlyRs from some invertebrate and vertebrate organisms. The polypeptide also contains the PAR motif, which is important for forming anion channels, and a conserved glycine residue at the third transmembrane domain, which is essential for high ivermectin sensitivity. PCR analyses showed that RmGlyR is expressed at egg, larval and adult developmental stages. Our findings suggest that the deduced receptor is an additional molecular target to ivermectin and it might be involved in ivermectin resistance in R. microplus.
    Parasite 01/2014; 21:43. · 0.82 Impact Factor

Full-text (2 Sources)

Available from
May 20, 2014